{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:19:28Z","timestamp":1782771568939,"version":"3.54.5"},"publisher-location":"Cham","reference-count":38,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319754017","type":"print"},{"value":"9783319754024","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-75402-4_4","type":"book-chapter","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:23:42Z","timestamp":1525253022000},"page":"29-35","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Alterations in Extracellular Matrix\/Bruch\u2019s Membrane Can Cause the Activation of the Alternative Complement Pathway via Tick-Over"],"prefix":"10.1007","author":[{"given":"Rosario","family":"Fernandez-Godino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,3]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S0002-9394(02)01624-0","volume":"134","author":"DH Anderson","year":"2002","unstructured":"Anderson DH, Mullins RF, Hageman GS et al (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134:411\u2013431","journal-title":"Am J Ophthalmol"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.biomaterials.2004.05.011","volume":"26","author":"J Andersson","year":"2005","unstructured":"Andersson J, Ekdahl KN, Lambris JD et al (2005) Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials 26:1477\u20131485","journal-title":"Biomaterials"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0167-5699(87)90167-8","volume":"8","author":"JP Atkinson","year":"1987","unstructured":"Atkinson JP, Farries T (1987) Separation of self from non-self in the complement system. Immunol Today 8:212\u2013215","journal-title":"Immunol Today"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1016\/j.molimm.2007.11.003","volume":"45","author":"F Bexborn","year":"2008","unstructured":"Bexborn F, Andersson PO, Chen H et al (2008) The tick-over theory revisited: formation and regulation of the soluble alternative complement C3 convertase (C3(H2O)Bb). Mol Immunol 45:2370\u20132379","journal-title":"Mol Immunol"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"14682","DOI":"10.1073\/pnas.222551899","volume":"99","author":"JW Crabb","year":"2002","unstructured":"Crabb JW, Miyagi M, Gu X et al (2002) Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci U S A 99:14682\u201314687","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/B978-1-4557-0737-9.00020-5","volume":"1","author":"CA Curcio","year":"2013","unstructured":"Curcio CA, Johnson M (2013) Structure, function, and pathology of Bruch\u2019s membrane. Retina 1:465\u2013481","journal-title":"Retina"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-1-4614-3209-8_28","volume":"801","author":"JD Ding","year":"2014","unstructured":"Ding JD, Kelly U, Groelle M et al (2014) The role of complement dysregulation in AMD mouse models. Adv Exp Med Biol 801:213\u2013219","journal-title":"Adv Exp Med Biol"},{"key":"4_CR8","volume":"11","author":"JR Evans","year":"2012","unstructured":"Evans JR, Lawrenson JG (2012) Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev 11:CD000254","journal-title":"Cochrane Database Syst Rev"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1093\/hmg\/ddv287","volume":"24","author":"R Fernandez-Godino","year":"2015","unstructured":"Fernandez-Godino R, Garland DL, Pierce EA (2015) A local complement response by RPE causes early-stage macular degeneration. Hum Mol Genet 24:5555\u20135569","journal-title":"Hum Mol Genet"},{"key":"4_CR09","doi-asserted-by":"crossref","unstructured":"Fernandez-Godino R, Bujakowska KM, Pierce EA (2018) Hum Mol Genet 27(1):147\u2013159","DOI":"10.1093\/hmg\/ddx392"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1093\/hmg\/ddm198","volume":"16","author":"L Fu","year":"2007","unstructured":"Fu L, Garland D, Yang Z et al (2007) The R345W mutation in EFEMP1 is pathogenic and causes AMD-like deposits in mice. Hum Mol Genet 16:2411\u20132422","journal-title":"Hum Mol Genet"},{"key":"4_CR11","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3928\/23258160-20131217-01","volume":"45","author":"CA Garcia Filho","year":"2014","unstructured":"Garcia Filho CA, Yehoshua Z, Gregori G et al (2014) Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration. Ophthalmic Surg Lasers Imaging Retina 45:18\u201331","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1093\/hmg\/ddt395","volume":"23","author":"DL Garland","year":"2014","unstructured":"Garland DL, Fernandez-Godino R, Kaur I et al (2014) Mouse genetics and proteomic analyses demonstrate a critical role for complement in a model of DHRD\/ML, an inherited macular degeneration. Hum Mol Genet 23:52\u201368","journal-title":"Hum Mol Genet"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S1350-9462(01)00010-6","volume":"20","author":"GS Hageman","year":"2001","unstructured":"Hageman GS, Luthert PJ, Victor Chong NH et al (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch\u2019s membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20:705\u2013732","journal-title":"Prog Retin Eye Res"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1073\/pnas.0501536102","volume":"102","author":"GS Hageman","year":"2005","unstructured":"Hageman GS, Anderson DH, Johnson LV et al (2005) A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A 102:7227\u20137232","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1111\/j.1582-4934.2008.00350.x","volume":"12","author":"M Harboe","year":"2008","unstructured":"Harboe M, Mollnes TE (2008) The alternative complement pathway revisited. J Cell Mol Med 12:1074\u20131084","journal-title":"J Cell Mol Med"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.4049\/jimmunol.160.12.6128","volume":"160","author":"EJ Hindmarsh","year":"1998","unstructured":"Hindmarsh EJ, Marks RM (1998) Complement activation occurs on subendothelial extracellular matrix in vitro and is initiated by retraction or removal of overlying endothelial cells. J Immunol 160:6128\u20136136","journal-title":"J Immunol"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1001\/archopht.1967.00980020412022","volume":"77","author":"MJ Hogan","year":"1967","unstructured":"Hogan MJ, Alvarado J (1967) Studies on the human macula. IV. Aging changes in Bruch\u2019s membrane. Arch Ophthalmol 77:410\u2013420","journal-title":"Arch Ophthalmol"},{"key":"4_CR18","first-page":"109","volume":"21","author":"PJ Lachmann","year":"1975","unstructured":"Lachmann PJ, Halbwachs L (1975) The influence of C3b inactivator (KAF) concentration on the ability of serum to support complement activation. Clin Exp Immunol 21:109\u2013114","journal-title":"Clin Exp Immunol"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1083\/jcb.103.3.1091","volume":"103","author":"I Leivo","year":"1986","unstructured":"Leivo I, Engvall E (1986) C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast. J Cell Biol 103:1091\u20131100","journal-title":"J Cell Biol"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/eci.12419","volume":"45","author":"DC Mastellos","year":"2015","unstructured":"Mastellos DC, Yancopoulou D, Kokkinos P et al (2015) Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention. Eur J Clin Investig 45:423\u2013440","journal-title":"Eur J Clin Investig"},{"issue":"1\u201335","key":"4_CR21","volume":"155","author":"JW Miller","year":"2013","unstructured":"Miller JW (2013a) Age-related macular degeneration revisited\u2013piecing the puzzle: the LXIX Edward Jackson memorial lecture. Am J Ophthalmol 155(1\u201335):e13","journal-title":"Am J Ophthalmol"},{"issue":"1\u201335","key":"4_CR22","volume":"155","author":"JW Miller","year":"2013","unstructured":"Miller JW (2013b) Age-related macular degeneration revisited\u2013piecing the puzzle: the LXIX Edward Jackson memorial lecture. Am J Ophthalmol 155(1\u201335):e13","journal-title":"Am J Ophthalmol"},{"key":"4_CR23","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1096\/fasebj.14.7.835","volume":"14","author":"RF Mullins","year":"2000","unstructured":"Mullins RF, Russell SR, Anderson DH et al (2000) Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J (Official Publication of the Federation of American Societies for Experimental Biology) 14:835\u2013846","journal-title":"FASEB J (Official Publication of the Federation of American Societies for Experimental Biology)"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.imbio.2012.07.008","volume":"217","author":"B Nilsson","year":"2012","unstructured":"Nilsson B, Nilsson Ekdahl K (2012) The tick-over theory revisited: is C3 a contact-activated protein? Immunobiology 217:1106\u20131110","journal-title":"Immunobiology"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1073\/pnas.0408835103","volume":"103","author":"M Nozaki","year":"2006","unstructured":"Nozaki M, Raisler BJ, Sakurai E et al (2006) Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A 103:2328\u20132333","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrc1821","volume":"6","author":"CM Overall","year":"2006","unstructured":"Overall CM, Kleifeld O (2006) Tumour microenvironment\u00a0\u2013 opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer 6:227\u2013239","journal-title":"Nat Rev Cancer"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1084\/jem.154.3.856","volume":"154","author":"MK Pangburn","year":"1981","unstructured":"Pangburn MK, Schreiber RD, Muller-Eberhard HJ (1981) Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J Exp Med 154:856\u2013867","journal-title":"J Exp Med"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.imbio.2012.06.003","volume":"218","author":"H Qu","year":"2013","unstructured":"Qu H, Ricklin D, Bai H et al (2013) New analogs of the clinical complement inhibitor compstatin with subnanomolar affinity and enhanced pharmacokinetic properties. Immunobiology 218:496\u2013505","journal-title":"Immunobiology"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000187632","volume":"190","author":"E Reale","year":"2009","unstructured":"Reale E, Groos S, Eckardt U et al (2009) New components of \u2018basal laminar deposits\u2019 in age-related macular degeneration. Cells Tissues Organs 190:170\u2013181","journal-title":"Cells Tissues Organs"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.4049\/jimmunol.1203487","volume":"190","author":"D Ricklin","year":"2013","unstructured":"Ricklin D, Lambris JD (2013) Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol 190:3831\u20133838","journal-title":"J Immunol"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K et al (2010) Complement: a key system for immune surveillance and homeostasis. Nat Immunol 11:785\u2013797","journal-title":"Nat Immunol"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1136\/bjo.83.3.358","volume":"83","author":"SH Sarks","year":"1999","unstructured":"Sarks SH, Arnold JJ, Killingsworth MC et al (1999) Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study. Br J Ophthalmol 83:358\u2013368","journal-title":"Br J Ophthalmol"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ng.2741","volume":"45","author":"JM Seddon","year":"2013","unstructured":"Seddon JM, Yu Y, Miller EC et al (2013) Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet 45:1366\u20131370","journal-title":"Nat Genet"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00011-008-7166-y","volume":"57","author":"P Sivakumar","year":"2008","unstructured":"Sivakumar P, Das AM (2008) Fibrosis, chronic inflammation and new pathways for drug discovery. Inflamm Res 57:410\u2013418","journal-title":"Inflamm Res"},{"key":"4_CR35","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10557-005-5417-5","volume":"19","author":"DN Tziakas","year":"2005","unstructured":"Tziakas DN, Chalikias GK, Hatzinikolaou HI et al (2005) Levosimendan use reduces MMP-2 in patients with decompensated heart failure. Cardiovasc Drugs Ther 19:399\u2013402","journal-title":"Cardiovasc Drugs Ther"},{"key":"4_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010329","volume":"5","author":"L Wang","year":"2010","unstructured":"Wang L, Clark ME, Crossman DK et al (2010) Abundant lipid and protein components of drusen. PLoS One 5:e10329","journal-title":"PLoS One"},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.ophtha.2013.09.044","volume":"121","author":"Z Yehoshua","year":"2014","unstructured":"Yehoshua Z, de Amorim Garcia Filho CA, Nunes RP et al (2014) Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. Ophthalmology 121:693\u2013701","journal-title":"Ophthalmology"}],"container-title":["Advances in Experimental Medicine and Biology","Retinal Degenerative Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-75402-4_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T07:08:57Z","timestamp":1693638537000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-75402-4_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319754017","9783319754024"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-75402-4_4","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}